Buda Juice Inc

Buda Juice Inc(BUDA)の株式分析

$6.550

-0.069 (-1.06%)終値時点

Loading chart…
高値
7.115
始値
7.115
出来高加重平均価格
6.65
出来高
5.98K
時価総額
—
安値
6.300
売買代金
39.81K
EV/EBITDA(TTM)
27.16

Buda Juice, Inc. operates in a beverage industry, focused on UltraFresh juice-offering cold-crafted citrus-based drinks. The Company offers an end-to-end cold chain platform that always delivers cold, freshly crafted juice, lemonades and wellness shots to grocery retailers in Texas. Its product portfolio consists of fresh citrus juice, a fresh citrus-based line of lemonades and wellness shot offerings across multiple brand lines and retail customers, all produced using its cold chain process. Its products include Buda Juice (Organic), Buda Fresh - Value-Forward Offering (Non-Organic), and Private Label Products (Non-organic and Organic). Buda Fresh includes Fresh 12 oz Lime Juice, 16 oz and 128 oz Lemon Juice, Fresh Orange and Grapefruit Juice (16 oz, 32 oz and 52 oz), and Fresh Citrus-based Lemonades and Limeades (16 oz and 52 oz). Private Label Products include Fresh Citrus Line (52 oz) and Fresh Citrus-based Lemonades and Limeades (52 oz).

www.budajuice.com

AI分析 of Buda Juice Inc (BUDA)

買い

Buda Juice appears to be a strong buy at the current price of $7.22, especially with an RSI of 62.22 indicating bullish momentum. The stock has a significant upside potential with an analyst price target of $12, suggesting a potential gain of 66.67%. Additionally, the company has shown robust revenue growth, with Q2 2026 revenue reaching $4.5 million, a substantial increase compared to previous quarters. However, investors should be cautious of the forward P/E ratio of 49.02, which indicates that the stock may be overvalued if growth does not meet expectations.

バリュエーション指標

Buda Juice Inc(BUDA)の現在の予想PERは49.26で、5年平均は48.93です。

予想PER

適正
5年平均 P/E
48.93
現在のP/E
49.26
割高
50.18
割安
47.68

予想EV/EBITDA

適正
5年平均 EV/EBITDA
49.93
現在のEV/EBITDA
27.16
割高
179.76
割安
-79.90

予想PSR

適正
5年平均 P/S
170.84
現在のP/S
4.00
割高
1138.27
割安
-796.59

イベントタイムライン

2026-08-13 (ET)

07:30:00

Buda Juice Reports Q2 Revenue of $4.5M

2026-05-26 (ET)

07:10:00

Buda Juice Dual Lists on NYSE Texas Effective May 26, 2026

2026-05-13 (ET)

07:10:00

Buda Juice Reports Q1 Adjusted EPS of 5 Cents, Revenue of $3.5M

2026-05-11 (ET)

07:00:00

Buda Juice Launches New Drink in 246 Walmart Stores

2026-03-26 (ET)

07:10:00

Buda Juice Reports FY25 Revenue of $12.6M

ニュース

BUDA のよくある質問 — Alphio AI が回答

Buda Juice, Inc. operates in a beverage industry, focused on UltraFresh juice-offering cold-crafted citrus-based drinks. The Company offers an end-to-end cold chain platform that always delivers cold, freshly crafted juice, lemonades and wellness shots to grocery retailers in Texas. Its product portfolio consists of fresh citrus juice, a fresh citrus-based line of lemonades and wellness shot offerings across multiple brand lines and retail customers, all produced using its cold chain process. Its products include Buda Juice (Organic), Buda Fresh - Value-Forward Offering (Non-Organic), and Private Label Products (Non-organic and Organic). Buda Fresh includes Fresh 12 oz Lime Juice, 16 oz and 128 oz Lemon Juice, Fresh Orange and Grapefruit Juice (16 oz, 32 oz and 52 oz), and Fresh Citrus-based Lemonades and Limeades (16 oz and 52 oz). Private Label Products include Fresh Citrus Line (52 oz) and Fresh Citrus-based Lemonades and Limeades (52 oz). It operates in the Consumer Non-Cyclicals sector.

Buda Juice appears to be a strong buy at the current price of $7.22, especially with an RSI of 62.22 indicating bullish momentum. The stock has a significant upside potential with an analyst price target of $12, suggesting a potential gain of 66.67%. Additionally, the company has shown robust revenue growth, with Q2 2026 revenue reaching $4.5 million, a substantial increase compared to previous quarters. However, investors should be cautious of the forward P/E ratio of 49.02, which indicates that the stock may be overvalued if growth does not meet expectations.

コミュニティ

もっと見る ↗

投稿はまだありません

登録またはログインして議論に参加

関連記事

本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。

取引を始める